Page last updated: 2024-08-23

bezafibrate and Burkitt Lymphoma

bezafibrate has been researched along with Burkitt Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banda, K; Bunce, CM; Drayson, MT; Dunn, JA; Iqbal, G; Khanim, FL; Merrick, B; Molyneux, E	1

Trials

1 trial(s) available for bezafibrate and Burkitt Lymphoma

Article	Year
Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497). British journal of haematology, 2014, Volume: 164, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Burkitt Lymphoma; Child; Child, Preschool; Drug Resistance, Neoplasm; Endemic Diseases; Female; Humans; Malawi; Male; Medroxyprogesterone Acetate; Recurrence	2014

Article

Year

Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).

British journal of haematology, 2014, Volume: 164, Issue:6

Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Burkitt Lymphoma; Child; Child, Preschool; Drug Resistance, Neoplasm; Endemic Diseases; Female; Humans; Malawi; Male; Medroxyprogesterone Acetate; Recurrence

2014